COURTNEY DONARUM: Open Payments
NPI 1780045575 · NEW BRITAIN, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$380 in 16 payments from 9 companies in 2025. Trend: 2023 $224 · 2024 $491 · 2025 $380
Food & beverage: $380
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 4 | $96 |
| E.R. Squibb & Sons, L.L.C. | 3 | $86 |
| Galderma Laboratories, L.P. | 2 | $43 |
| Novartis Pharmaceuticals Corporation | 2 | $41 |
| LEO Pharma Inc. | 1 | $29 |
| GENZYME CORPORATION | 1 | $26 |
| LNHC, Inc | 1 | $21 |
| Botanix SB Inc | 1 | $20 |
| ABBVIE INC. | 1 | $17 |
Products named: TREMFYA, Sotyktu, NEMLUVIO, ANZUPGO, DUPIXENT, COSENTYX, ZELSUVMI, SOFDRA.
Industry payments across CT — which companies pay providers there.
